blood glucose

The OD’s role with new diabetes drugsIt is important for eyecare providers to be familiar with these new drugs and findings. We often see patients with diabetes, metabolic syndrome, and high CV risk, and we are in a position to help counsel our patients about new treatments—and even suggest that appropriate patients have conversations with their primary-care physicians, endocrinologists and cardiologists.
Novel device helps diabetics avoid stress linked to glucose testingFDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.
New strategies to assess the risk of diabetes-related vision lossA colleague recently told me that eye doctors should “stay within the lines” of traditional eye care because we barely have enough time as it is to do our jobs. My response was that today more than half of our adult patients have either diabetes or prediabetes, so our job now requires we go ”outside the lines” to avoid the leading cause of preventable blindness.
How diabetes is linked to gut bacteriaGiven this abundance of nonhuman species living on and within our bodies, it is not surprising that there is a link between specific bacteria to systemic and ocular disease—including diabetes and diabetes-related eye disease.
Five advancements in diabetes treatment to watch
Five advancements in diabetes treatment to watchThe healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.
Study: New Diabetes Drug Class Reduces Heart DeathsNew class of glucose-lowering agents lowers hospitalization and death rates even in Type 2 patients without heart disease.
What providers need to do to improve chronic care
What providers need to do to improve chronic careA West survey finds that an overwhelming number of chronic care patients say they need help managing their disease.
How reducing pain of checking blood sugar lowers cost, improves outcomesHere are 3 reasons why overcoming the “fingerstick” barrier will improve patient outcomes and contribute to reductions in healthcare costs.
Insurer diabetes program engages consumers, lowers costs
Insurer diabetes program engages consumers, lowers costsAnthem Blue Cross recently launched a year-long diabetes prevention program to educate, treat and support its qualified California members who are at risk of developing type 2 diabetes.
Aggressive blood sugar control slows diabetic eye disease progressionNIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control.